AbbVie gains EU approval for Rinvoq to treat pediatric arthritis

RegulatoryapprovedRinvoqPositive

AI Analysis

AbbVie has obtained European Union approval for Rinvoq to treat pediatric arthritis, expanding the drug's label in the EU market.

EU approval for pediatric arthritis indication

Importance:7/10

Sentiment:

0.80

EU approvalregulatorypediatric indicationrheumatology

Related Companies

Read the original article

Published by Seeking Alpha Healthcare on September 22, 2026 6:30 AM